Electrical impedance measuring method for differentiating tissue types

• US 20030105411A1
• Filed: 09/20/2002
• Published: 06/05/2003
• Est. Priority Date: 03/03/2000
• Status: Abandoned Application

• Current Assignee: BTG International Limited (Boston Scientific Corporation)
• Original Assignee: BTG International Limited (Boston Scientific Corporation)
• Inventors: Brown, Brian Hilton, Smallwood, Rodney Harris, Boston, Karen Julie, Blackett, Anthony David, Tidy, John Anthony
• Application Number:
  US10/220,571
• Publication Number:
  US 20030105411A1
• Time in Patent Office: Days
• US Class Current: 600/547
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body

Abstract

A method for differentiating tissue types, which is suitable as a method for obtaining data to enable a cancer screening process, comprises applying an alternating electric current to an area of tissue across a range of frequencies. The tissue impedance is measured at each frequency and the results fitted to a Cole equation. It has been found that the method is good at distinguishing between tissues having different size nuclei, or different ratios of nuclear to cytoplasm volume. This is related to the resistance (S) to electrical current flow through cytoplasm. Results may be improved by combining S with a value (R) for the resistance offered to electrical current through pathways between the cells. The method may be used in vivo or in vitro.

Claims

1. A method of differentiating in a given area of tissue two or more tissue types whose cells have nuclei of different sizes, the method comprising the steps of:

(a) applying an alternating electric current to the area of tissue across a range of frequencies;

(b) measuring the tissue impedance at each frequency;

(c) deriving from the results an intracellular resistance value S representing electrical resistance offered by cytoplasm; and

(d) based on the value S, differentiating the tissue types.

4. A method as claimed in any of claims 1 to 3 wherein the range of frequencies includes a frequency in the range 50 kHz to 1.5 MHz.

5. A method as claimed in any of claims 1 to 4 further comprising:

(a) deriving from the results an extracellular resistance value R representing electrical resistance offered by current pathways between cells in the said area of tissue; and

(b) making said determination or differentiation step based on a combination of the values R and S.

6. A method as claimed in claim 5 wherein the said combination of R and S is R/S or S/R.

7. A method as claimed in any preceding claim wherein the value S and/or the value R is derived by fitting the results to a Cole equation of the form:

2. A method of screening for the presence of potentially cancerous or pre-cancerous tissue comprising cells having enlarged cell nuclei, the method comprising:

(a) applying an alternating electric current to an area of tissue across a range of frequencies;

(b) measuring the tissue impedance at each frequency;

(c) deriving from the results an intracellular resistance value S representing electrical resistance offered by cytoplasm; and

(d) based on the value S, making a determination as to whether further investigation by biopsy or another method is required.

3. A method of analysing tissue biopsy samples for the presence of cancerous or pre-cancerous tissue comprising cells having enlarged cell nuclei, the method comprising:

(a) taking a tissue biopsy from a human or animal;

(b) applying an alternating electric current to the tissue across a range of frequencies;

(c) measuring the tissue impedance at each frequency;

(d) deriving from the results an intracellular resistance value S representing electrical resistance offered by cytoplasm; and

(e) based on the value S, making a determination of the probability of cancerous or pre-cancerous tissue being present.